DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Fexofenadine Hydrochloride Hives is a drug marketed by Dr Reddys Labs Ltd, Mylan, Sciegen Pharms Inc, Sun Pharm Inds, Teva, and Wockhardt Ltd. and is included in six NDAs.
The generic ingredient in FEXOFENADINE HYDROCHLORIDE HIVES is fexofenadine hydrochloride. There are twenty-three drug master file entries for this compound. One hundred and two suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride profile page.
A generic version of FEXOFENADINE HYDROCHLORIDE HIVES was approved as fexofenadine hydrochloride by TEVA on September 1st, 2005.
Recent Clinical Trials for FEXOFENADINE HYDROCHLORIDE HIVES
Identify potential brand extensions & 505(b)(2) entrants
|Tanta University||Phase 4|
|Assistance Publique - Hôpitaux de Paris||Phase 4|